Concepedia

Anil Singhal

AS

57

Publications

6.6K

Citations

29

H-Index

1978

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Bristol-Myers Squibb (United States)

Emory University

Princess Margaret Cancer Centre

AbbVie (United States)

Anil Singhal is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1978–2020

57

Publications

57

ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le <sup>x</sup>

M. Laurie Phillips, Edward Nudelman, F C Gaeta et al. · Science · 1990 · 1.3K citations

, , +20

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text

CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x.

Margaret J. Polley, M. Laurie Phillips, Elizabeth A. Wayner et al. · Proceedings of the National Academy of Sciences · 1991 · 501 citations · Full text

, , +18

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma

Jeffrey A. Zonder, Ann Mohrbacher, Seema Singhal et al. · Blood · 2011 · 339 citations · Full text

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

Shengle Zhang, H S Zhang, Carlos Cordon‐Cardo et al. · International Journal of Cancer · 1997 · 293 citations · Full text

Rows per page

1–5 of 57